Cargando…
Jujuboside A Ameliorates Myocardial Apoptosis and Inflammation in Rats with Coronary Heart Disease by Inhibiting PPAR-α Signaling Pathway
BACKGROUND: Coronary heart disease (CHD) is a chronic disease caused by atherosclerosis (AS), which can cause myocardial ischemia, hypoxia, or necrosis, seriously threatening human health. There is an urgent need for effective treatments and drugs to reduce the various risk factors for coronary hear...
Autores principales: | Hu, Chunfang, Zhang, Zhiyuan, Song, Guixian, Zhu, Li, Wang, Ruzhu, Ruan, Zhongbao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249489/ https://www.ncbi.nlm.nih.gov/pubmed/35783519 http://dx.doi.org/10.1155/2022/2285728 |
Ejemplares similares
-
Retracted: Jujuboside A Ameliorates Myocardial Apoptosis and Inflammation in Rats with Coronary Heart Disease by Inhibiting PPAR-α Signaling Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
MicroRNA-132 attenuated cardiac fibrosis in myocardial infarction-induced heart failure rats
por: Wang, Guoyu, et al.
Publicado: (2020) -
Puerarin inhibits apoptosis and inflammation in myocardial cells via PPARα expression in rats with chronic heart failure
por: He, Le, et al.
Publicado: (2019) -
Jujuboside A promotes Aβ clearance and ameliorates cognitive deficiency in Alzheimer's disease through activating Axl/HSP90/PPARγ pathway
por: Zhang, Mu, et al.
Publicado: (2018) -
Predictive value of inflammatory factors on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Chu, Xin, et al.
Publicado: (2021)